Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2013-06-30
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
From 2022 onwards, PA patients diagnosed or subtyped with adrenal vein sampling at Oslo University Hospital will additionally be included in the study, thereby providing a national registration of PA patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment
NCT01728493
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
NCT04761354
Identification of Patient Phenotypes Associated With Elevated Aldosterone Levels
NCT01614860
Electronic Alert to Improve Testing For Primary Aldosteronism in Patients With Hypertension
NCT05925569
Outcome of Patients With Primary Aldosteronism
NCT04428827
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A subgroup of the included PA study patients also perform a Cardiac MRI. Cine-MRI, velocity-encoded MRI, MRI images during continuous adenosine infusion and MRI images after gadolinium contrast injection are performed, and compared to a group of age- and sex-matched healthy controls.
From 2025 onwards, PA patients either diagnosed or performing subtyping with adrenal vein sampling at Oslo University Hospital will likewise be asked for study inclusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Primary aldosteronism patients for cardiac MRI
A subgroup of primary aldosteronism (PA) patients perform a cardiac MRI, including stress-testing with adenosine, and are compared to a sex- and age-matched group of healthy controls who perform the same MRI procedure
No interventions assigned to this group
Healthy controls
Healthy controls that are age-and sex-matched to the subgroup of PA patients performing cardiac MRI, perform MRI including adenosine as stress-test.
No interventions assigned to this group
Primary aldosteronism patients diagnosed from 2013 onwards
All PA patients diagnosed or subtyped at Haukeland University from 2013 onwards are asked for inclusion in the main observational PA-study.
From 2025 onwards, PA patients diagnosed or subtyped at Oslo University hospital will also be included.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-85
Exclusion Criteria
* Asthma/chronic obstructive pulmonary disease ,
* Use of dipyridamole
* Claustrophobia
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Helse Stavanger HF
OTHER_GOV
Helse Fonna
OTHER
University Hospital of North Norway
OTHER
St. Olavs Hospital
OTHER
Alesund Hospital
OTHER
Haukeland University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marianne A Grytaas, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Haukeland University Hospital
Anders P Jørgensen, MD PhD
Role: STUDY_DIRECTOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland University Hospital
Bergen, , Norway
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/742
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.